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The molybdenum cofactor of formylmethanofuran dehydrogenase from methanol-grown Methanosarcina b rkeri was isolated as the [di(carboxami- 
domethyl)]-derivative. Th  alkylated factor showed an absorption spectrum and chemical properties identical to those recently reported for the 
molybdenum cofactor of dimethyl sulfoxide reductase from Rhodobacter sphaeroides. By treatment with nucleotide pyrophosphatase th factor 
was resolved into two components, which were identified as [di(carboxamidomethyl)]-molybdopterin and GMP by their absorption spectra, their 
retention times on Lichrospher RP-18, and by their conversion todephospho-[di(carboxamidomethyl)]-molybdopterin an  guanosine, respectively, 
in the presence ofalkaline phosphatase. The GMP-moiety was sensitive to periodate, identifying it as the 5'-isomer. These results demonstrate 
that the molybdenum cofactor isolated from formylmethanofuran dehydrogenase contains the phosphoric anhydride of molybdopterin a d 5'- 
GMP. 
Molybdopterin cofactor; Formylmethanofuran dehydrogenase; M thanogenic archaebacteria; Methanosarcina b rkeri 
1. INTRODUCTION 
Formylmethanofuran dehydrogenase is a molyb- 
doenzyme [1,2] involved in the energy metabolism of 
methanogenic archaebacteria [3,4]. Besides 
molybdenum the enzyme contains a pterin cofactor of 
apparent molecular mass 780 Da [5]. A pterin cofactor 
of this size has first been reported to be present in car- 
bon monoxide dehydrogenase from Pseudomonas car- 
boxydoflava [6,7] and was later found in many other 
eubacterial molybdoenzymes [8,9]. Whereas the pterin 
cofactor of eucaryotic molybdoenzymes has been 
reported to have an apparent molecular mass of only 
340 Da [10]. 
The 340 Da pterin found in eucaryotes i designated 
molybdopterin (MPT) (Fig. 1A) [11]. It is isolated in the 
presence of iodoacetamide as the [di(carbox- 
amidomethyl)]-derivative (camMPT) (Fig. 1B). The 
structure of camMPT has been elucidated in 1987 by 
Kramer et al. [12]. It confirmed the structure proposed 
earlier for MPT [13]. 
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The larger pterin found in eubacteria is composed of 
molybdopterin, an additional phosphate, and an 
aromatic residue. This was known since 1986 by the 
work of Meyer and collaborators [6,7,14]. The struc- 
ture of the compound remained, however, obscure until 
recently. Johnson et al. [15] reported that the pterin 
cofactor of dimethyl sulfoxide reductase from 
Rhodobacter sphaeroides contains molybdopterin and 
5 ' -GMP connected via a pyrosphosphate bond. The 
novel cofactor was, in analogy to FMN and FAD, 
designated molybdopterin guanine dinucleotide 
(MGD). The structures of MGD and of its [di(carbox- 
amidomethyl)]-derivative (camMGD) are shown in Fig. 
IC,D. 
In the meantime the structure of the pterin cofactor 
of carbon monoxide dehydrogenase from P. carbox- 
ydoflava has also been determined [16]. Surprisingly 
the prosthetic group of this enzyme turned out to be ~~ 
molybdopterin cytosine dinucleotide (MCD). It thus 
appears that different molybdoenzymes contain dif- 
ferent molybdopterin dinucleotides. 
We report here that the molybdenum pterin cofactor 
of formylmethanofuran dehydrogenase from the ar- 
chaebacterium Methanosarcina barkeri is a molyb- 
dopterin guanine dinucleotide and thus identical to that 
of dimethyl sulfoxide reductase from the eubacterium 
R. sphaeroides. 
2. MATERIALS AND METHODS 
lodoacetamide was from Merck-Schuchard (Darmstadt, FRG). 
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Fig. 1. Proposed structure of the oxidized forms of (A) molybdopterin (MPT); (B) [di(carboxamidomethyl)]-molybdopterin (camMPT); (C) 
molybdopterin guanine dinucleotide (MGD); and (D) [di(carboxamidomethyl)]-molybdopterin guani e dinucleotide (camMGD) [15]. 
Xanthine oxidase (EC 1.1.3.22) (1 U/mg) and periodic acid were from 
Serva (Heidelberg, FRG), nucleotide pyrophosphatase (EC 3.6.1.9) 
Type III (4-8 U/mg) and guanosine 5'-monophosphate w re from 
Sigma (Deisenhofen, FRG). Alkaline phosphatase (EC 3.1.3.1) (1 
U/#l) was from Boehringer-Mannheim (Mannheim, FRG). For- 
mylmethanofuran dehydrogenase from M. barkeri (strain Fusaro) 
(DSM 804) was purified as described [2]. 
The molybdenum cofactor of formylmethanofuran dehydrogenase 
from M. barkeri was isolated as the [di(carboxamidomethyl)]- 
derivative. The initial purification steps were performed in an 
anaerobic chamber (Coy, Ann Arbor, USA). Four mg iodoacetamide 
were added to 4 mg purified enzyme in 2 ml of an anaerobic 10 mM 
sodium phosphate buffer, pH 7.0. Then 25 #1 of a 100 mM sodium 
dithionite solution was added followed by 25 mg SDS. The 8 ml vial 
was closed with a rubber stopper and incubated for two hours in a 
water bath at 37°C. After overnight incubation at room temperature 
the reaction mixture was subjected to ultrafiltration using 
Centricon-10 microconcentrators (Amicon, Witten, FRG). The 
filtrate was concentrated bylyophilization, dissolved in 10 mM acetic 
acid, and desalted on a Sephadex GI5 column (44 × 1 cm) 
equilibrated with 10 mM acetic acid. Fractions containing pterin were 
identified by their characteristic fluorescence (380 nm excitation, 460 
nm emission) after alkalization of fraction aliquots with NaOH. The 
pterin-containing fractions were neutralized with NH3 and concen- 
trated by rotoevaporation. Final purification of the [di(carbox- 
amidomethyl)]-derivative was achieved by chromatography on a C-18 
HPLC column (125 x 4 mm, Lichrospher 100 RP-18 from Merck, 
Darmstadt, FRG) using 50 mM ammonium acetate, pH 6.8, contain- 
ing 3070 (v/v) methanol as eluent. Detection was via a Hewlett- 
Packard 1040A/1090A diode array detector connected to a Hewiett- 
Packard compactcomputer HP 85-B. Elution profiles were recorded 
at 280 nm. All absorption spectra were obtained on-line. 
Enzymatic hydrolysis of the purified [di(carboxamidomethyl)]- 
derivative was achieved by incubation in 50 mM ammonium acetate, 
pH 6.8, containing 10 mM MgCI2 in the presence of nucleotide 
pyrophosphatase (10 U) and, where indicated, also of alkaline 
phosphatase (10 U). The 150/~1 reaction mixtures were incubated at 
room temperature for 30 min and then aliquots (30-70 #l) analyzed 
for product formation by HPLC as described above. 
The molybdenum cofactor of milk xanthine oxidase was isolated as 
the [di(carboxamidomethyl)]-derivative essentially as described for 
the cofactor of formylmethanofuran dehydrogenase. The compound 
obtained showed a UV/VIS spectrum identical to that published for 
camMPT [15]. 
3. RESULTS 
When purified formylmethanofuran dehydrogenase 
is extracted with guanidine hydrochloride two fluores- 
cent compounds are obtained, one with an apparent 
molecular mass of 780 Da and the other with 430 Da. 
Both compounds are converted to pterin 6-carboxylic 
acid by oxidation with permanganate [5]. We now 
found that the 780 Da pterin is converted to the 430 Da 
pterin by treatment with nucleotide pyrophosphatase, 
an enzyme known to catalyze the cleavage of the 
pyrophosphate linkage of, example given, FAD or 
NAD. These findings indicated that the molybdenum 
cofactor of formylmethanofuran dehydrogenase is 
most probably a dinucleotide of molybdopterin and a 
aucleotide monophosphate as is the molybdenum 
:ofactor of dimethyl sulfoxide reductase from R. 
~phaeroides [ 15] and of carbon monoxide 
dehydrogenase from P. carboxydoflava [16]. 
3.1. Purification of  the [di(carboxamidomethyl)]- 
derivative of the molybdenum co factor 
The molybdenum cofactor of formylmethanofuran 
dehydrogenase from M. barkeri was isolated as the 
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[di(carboxamidomethyl)]-derivative essentially as 
described by Johnson et al. [15]. To an anaerobic sam- 
ple of the purified enzyme (4 mg protein) 
iodoacetamide and then sodium dodecyl sulfate were 
added at pH 7. After anaerobic incubation for 2 h at 
37°C and then for 12 h at room temperature protein 
was removed by ultrafiltration and the filtrate was 
lyophilized. The lyophilisate was dissolved in 10 mM 
acetic acid and applied to a Sephadex G15 column for 
the separation of the [di(carboxamidomethyl)]- 
derivative from low molecular weight compounds 
(iodoacetamide, SDS, buffer). The fractions containing 
the [di(carboxamidomethyl)]-derivative were pooled, 
neutralized with NH3, and concentrated by 
rotoevaporation. The slightly yellow residue was 
dissolved in 0.5 ml 50 mM ammonium acetate, pH 6.8, 
containing 3% (v/v) methanol. Aliquots (0.05-0.08 ml) 
of the solution were subjected to HPLC on Lichrospher 
100 RP-18. The elution profile is given in Fig. 2. The 
UV/VIS spectra of the 4 separated compounds are 
given in the inset. 
The compounds in peaks 1-3 did not show a pterin 
spectrum and are therefore not considered to be com- 
ponents of the molybdenum cofactor. The compound 
which eluted in peak 4, however, exhibited a UV/VIS 
spectrum characteristic for a [di(carboxamidomethyl)]- 
molybdopterin dinucleotide. This compound was 
therefore re-chromatographed on Lichrospher 100 
RP-18. It eluted in only 1 peak showing aUV/VIS spec- 
trum resembling very closely that published for 
camMGD (Fig. 3). 
3.2. Identification of  camMPT and 5'-GMP as 
products formed in the presence of nucleotide 
pyrophosphatase 
From the spectrum shown in Fig. 3 the nucleotide 
moiety of the molybdenum cofactor cannot definitively 
be identified. We therefore incubated the [di(carbox- 
amidomethyl)]-derivative at pH 6.8 in the presence of 
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Fig. 2. HPLC elution profile of the compounds extracted from 
formylmethanofuran dehydrogenase in the presence of 
iodoacetamide. The insets show the UV/VIS spectra of the 4 
compounds resolved. 
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Fig. 3. UV/VIS spectrum of the [di(carboxamidomethyl)]-derivative 
(peak 4 in Fig. 2) after re-chromatography on Lichrospher 100 RP-18. 
The inset shows the elution profile. 
nucleotide pyrophosphatase and separated the 
hydrolysis products by HPLC on Lichrospher 100 
RP-18 (Fig. 4). The product, which eluted first, showed 
the spectrum given in Fig. 4A. It was identified as GMP 
by its retention time and its characteristic UV/VIS spec- 
trum, which were identical to those of authentic GMP. 
The product, which eluted second, exhibited the spec- 
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Fig. 4. UV/VIS spectra of the two degradation products formed from 
the [di(carboxamidomethyl)]-derivative in the presence of nucleotide 
pyrophosphatase. The products were separated by HPLC on 
Lichrospher 100 RP-18. The insets show the elution profile. (A) 
Product 1 was identified as GMP; (B) product 2 was identified as 
camMPT (see text). 
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Fig. 5. HPLC elution profile (lower trace) of the products formed 
from the [di(carboxamidomethyl)]-derivative in the presence of 
nucleotide pyrophosphatase and alkaline phosphatase. The upper 
trace shows the elution profile of authentic dephospho-camMPT and 
of guanosine. 
its retention time and UV/VIS spectrum. The 
camMPT, which was used as reference substance, was 
isolated from milk xanthine oxidase after alkylation 
with iodoacetamide [ 12,15]. The data strongly indicate 
that the molybdenum cofactor of formylmethanofuran 
dehydrogenase from M. barkeri is a molybdopterin 
guanine dinucleotide. 
In a further experiment we incubated the [di(carbox- 
amidomethyl)]-dinucleotide at pH 6.8 in the presence of 
both nucleotide pyrophosphatase and alkaline 
phosphatase and separated the hydrolysis products by 
HPLC on Lichrospher 100 RP-18 (Fig. 5). The two pro- 
ducts showed retention times and UV/VIS spectra (data 
not shown) characteristic for guanosine and 
dephospho-camMPT. his finding further substan- 
tiates the fact that the molybdenum cofactor of for- 
mylmethanofuran dehydrogenase is composed of 
molybdopterin and guanosine monophosphate con- 
nected via a pyrophosphate bond. 
The GMP moiety was identified as 5'-GMP by in- 
cubation in the presence of periodate (0.1 mM) at pH 
4.5. The nucleotide was degraded as evidenced by 
HPLC (data not shown). Only 5' -nucleotides react with 
periodate under these conditions. 
4. DISCUSSION 
The available data indicate that at least 3 different 
molybdenum pterin cofactors exist: (i) molybdopterin 
(Fig. 1A) which is the prosthetic group of the eucaryotic 
molybdoenzyme xanthine oxidase, aldehyde oxidase, 
sulfite oxidase, and nitrate reductase [17,18]; (ii) 
molybdopterin guanine dinucleotide found in dimethyl 
sulfoxide reductase from R. sphaeroides [15] and in for- 
mylmetanofuran dehydrogenase from M. barkeri; and 
(iii) molybdopterin cytosine dinucleotide found in car- 
bon monoxide dehydrogenase from P. carboxydoflava 
[16]. Many other molybdoenzymes with a pterin cofac- 
tor are known. They have, however, not yet been 
analyzed: formate dehydrogenase, nitrate reductase 
[19], dimethyl sulfoxide reductase [20], trimethylamine 
N-oxide reductase [21], biotin sulfoxide reductase [17], 
nicotine dehydrogenase [22], nicotinic acid 
dehydrogenase, 6-hydroxynicotinic a id dehydrogenase 
[8,23], 2-furoyl-CoA dehydrogenase [24], arsenate 
reductase [17], picolinate dehydrogenase [25], and xan- 
thine dehydrogenase [26] from eubacteria, nd formate 
dehydrogenase from the archaebacterium Methano- 
bacteriumformicicum [27]. Some of these nzymes may 
turn out to contain a molybdopterin dinucleotide with 
a nucleotide other than GMP or CMP. This remains, 
however, to be demonstrated. 
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